Company news

KORU Medical Systems, Inc. news in 2024

KORU Medical Systems, Inc.'s news releases, calls and decks from 2024, newest first.

View company

KORU Medical Systems to Participate in Piper Sandler’s 36th Annual Healthcare Conference

November 24, 2024

KORU Medical Systems, Inc. Announces 2024 Q3 Financial Results, Third Consecutive Quarter of Double-Digit Growth; Raises Full Year 2024 Guidance

November 12, 2024

KORU Medical Systems Presents Data at Partnership Opportunities in Drug Delivery (PODD) Conference Demonstrating Nursing Preference for Use of KORU FreedomEdge® Infusion System over Manual Syringe Administration for Subcutaneous Oncology Infusion

October 30, 2024

KORU Medical Systems to Report Third Quarter 2024 Financial Results on November 13, 2024

October 22, 2024

KORU Medical Systems to Participate in the 8th Annual Lake Street Best Ideas Growth Conference

September 4, 2024

KORU Medical Systems, Inc. Announces 2024 Q2 Financial Results, a Record Quarter With 22% Revenue Growth; Raises Full Year 2024 Guidance

August 6, 2024

KORU Medical Systems to Participate in the Canaccord Genuity 44th Annual Growth Conference

July 24, 2024

KORU Medical Systems, Inc Announces Leadership Changes to Support Growth Agenda

July 23, 2024

KORU Medical Systems to Report Second Quarter 2024 Financial Results on August 7, 2024

July 16, 2024

KORU Medical Systems Receives Regulatory Clearance for FreedomEdge® Infusion System in Japan

July 1, 2024

Simplifying Subcutaneous Drug Administration: SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion

June 4, 2024

KORU Medical Systems Announces a New Feasibility Study with a Commercialized Oncology Biologic

June 3, 2024

KORU Medical Systems Signs Supply Agreement for a Phase III Clinical Trial for a Novel Endocrinological Biologic

May 13, 2024

KORU Medical Systems, Inc. Announces 2024 First Quarter Financial Results Delivering Double-Digit Revenue Growth

April 30, 2024

KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024

April 16, 2024

KORU Medical Systems Announces Successful Appeal in EU Notified Body Review

April 10, 2024

KORU Medical Systems to Present Data Demonstrating 97% Adherence on Its Freedom Infusion System for Large Volume Subcutaneous Administration at NHIA 2024 Conference

March 17, 2024

KORU Medical Systems, Inc. Announces 2023 Fourth Quarter, Full Year Financial Results, and 2024 Guidance

March 12, 2024

KORU Medical Systems Announces a Feasibility Study to Enter Ambulatory Infusion Settings with a Commercialized Biologic

March 10, 2024

KORU Medical Systems Signs a Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for a Novel Subcutaneous Immunoglobulin

March 5, 2024

KORU Medical Systems to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024

February 20, 2024

Calls in 2024

Decks in 2024